It’s time for Bits & Bytes…
… where we bring you news, innovations, and thought-provoking insights from AI, IT, and beyond. In this week’s newsletter we’re looking at:
- Meta scores a major win by poaching Apple’s top AI model lead.
- ChatGPT quietly experiments with a feature that could reshape how we study.
- Elon Musk sets the date for Grok 4 as the AI model wars heat up.
Before we begin, a message from our sponsor!
Activate your email channel into your startup’s secret sales weapon
IN THE SPOTLIGHT
✨ Meta Raids Apple’s AI Bench — Again
Apple’s head of AI models, Ruoming Pang, just jumped ship to join Meta’s newly formed Superintelligence Labs a major talent win for Zuckerberg’s bold AI ambitions.
While Apple’s in-house models have struggled to keep pace with rivals, Pang brings deep expertise in lightweight, on-device AI a key piece in building faster, smarter, more private AI assistants at Meta.
TL;DR
- Meta hires Apple’s top AI model leader, Ruoming Pang.
- Pang led the team behind Apple’s in-house foundation models.
- His exit signals deeper trouble in Apple’s AI division.
TECH HEADLINES FROM ACROSS THE WEB
🧑🎓 ChatGPT Might Become Your Next Study Buddy
OpenAI is quietly testing a new “Study Together” mode inside ChatGPT and it’s not just about giving answers. Instead, it flips the script: asking you questions, nudging you to think critically, and maybe even letting multiple users collaborate. It could be the start of a more responsible, interactive AI classroom.
🧭 AI is doing what middle managers used to do
Middle managers are quietly disappearing as AI takes over day-to-day oversight and companies slash layers to save costs. While it boosts efficiency, losing mentorship and support could backfire especially for junior employees still learning the ropes.
🚀 Grok 4 Drops July 9
Elon Musk just announced that xAI’s next-gen model, Grok 4, will launch on Wednesday, July 9. With rising competition from OpenAI and Google, all eyes are on how Grok will evolve and whether it can stand out in the race for smarter, faster, more human-like AI.
TECH FOR GOOD
🧬AI-Designed Cancer Drug Heads to Clinical Trials at Alphabet’s Isomorphic
Alphabet’s Isomorphic Labs is entering human trials with AI-designed cancer drugspowered by AlphaFold 3. Backed by $600M and pharma giants like Novartis, they’re aiming to turn drug discovery into a precise, scalable science with a bold mission to “solve all diseases.”
